Pure Global

HEMOGLOBINA GLICOSILADA (HBA1C) - INVIMA Registration 2043ac8eef32bbccab04c0b4d09aadc6

Access comprehensive regulatory information for HEMOGLOBINA GLICOSILADA (HBA1C) (GLYCOSYLATED HEMOGLOBIN (HBA1C) ) in the Colombia medical device market through Pure Global AI's free database. This medical device is registered under INVIMA analysis ID 2043ac8eef32bbccab04c0b4d09aadc6 and manufactured by DIAGNOSTILAB VM SAS. The device was registered on October 13, 2031.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.

Free Database
Powered by Pure Global AI
INVIMA Official Data
2043ac8eef32bbccab04c0b4d09aadc6
HEMOGLOBINA GLICOSILADA (HBA1C)
INVIMA Analysis ID: 2043ac8eef32bbccab04c0b4d09aadc6
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Product Type (Spanish)
REACTIVO DIAGNOSTICO
Product Type (English)
DIAGNOSTIC REAGENT
Registration Information
Analysis ID
2043ac8eef32bbccab04c0b4d09aadc6
Expire Date
October 13, 2031
Authorized Company / Fabricante
Name (Spanish)
DIAGNOSTILAB VM SAS
Name (English)
DIAGNOSTILAB VM SAS